Apixaban
High-purity pharmaceutical grade Apixaban manufactured to meet stringent USP/EP specifications for pharmaceutical formulations and research applications. Our pharmaceutical grade material delivers exceptional purity and consistency for critical pharmaceutical manufacturing.
- USP/EP Grade Specifications
- High Purity (≥99.0%)
- Comprehensive Analytical Testing
- Regulatory Compliance Documentation
- Pharmaceutical Manufacturing Grade
- Quality Assurance Certified
Technical Specifications
Applications
Industry-Specific Grades
DRAVYOM offers specialized Apixaban grades tailored for specific pharmaceutical requirements, ensuring optimal performance and regulatory compliance across diverse drug manufacturing applications.
USP Grade (Pharmaceutical)
EP Grade (European Pharmacopoeia)
Research Grade
GMP Grade
Quality Standards
DRAVYOM's pharmaceutical grade Apixaban is manufactured under stringent cGMP protocols, meeting international pharmaceutical standards including USP, EP, and ICH guidelines. Our pharmaceutical-grade production ensures consistent quality and regulatory compliance.
Advanced Chemical Properties & Performance
Pharmaceutical grade Apixaban exhibits exceptional chemical properties essential for anticoagulant therapy applications. Its ultra-pure composition and precise molecular structure ensure reliable performance in demanding pharmaceutical formulations and research applications.
Analytical Properties
Physical Properties
Pharmaceutical Performance
Purity Specifications
Stability Properties
Performance Characteristics
Detailed performance metrics demonstrate pharmaceutical grade Apixaban superiority in anticoagulant applications with exceptional Factor Xa inhibition efficacy, precision, and reproducibility across diverse thromboembolism prevention protocols and research procedures.
Pharmaceutical Performance
Assay: ≥99.0% active pharmaceutical ingredient
Exceptional purity for anticoagulant formulationsFactor Xa Inhibition
Efficacy: Direct selective inhibition
Superior anticoagulant selectivityDissolution Rate
Bioavailability: 50% oral absorption
Predictable pharmacokinetic profileThermal Stability
Working range: 15-25°C optimal storage
Maintains potency across temperature rangeBatch Consistency
Variation: ±0.2% between manufacturing batches
Exceptional lot-to-lot reproducibilityExtended Stability
3 years shelf life under recommended conditions
Long-term pharmaceutical grade integritySafety Information
Potent anticoagulant pharmaceutical requiring specialized handling procedures. Use appropriate personal protective equipment and follow institutional drug handling protocols. Avoid skin contact and inhalation. Handle in well-ventilated areas and ensure proper safety measures for bleeding risk compounds.
Storage & Handling
Store in original containers in a cool, dry area (15-25°C) away from light and incompatible materials. Keep containers tightly closed and protect from moisture. Use specialized pharmaceutical storage protocols for anticoagulant compounds and ensure proper material identification and segregation.
Chemical Mechanisms & Reaction Pathways
Apixaban exhibits direct factor Xa inhibition properties through selective binding to the active site, enabling precise anticoagulation applications with predictable pharmacokinetic pathways and quantitative blood clotting prevention mechanisms.
Factor Xa Inhibition
Direct and reversible inhibition of factor Xa enzyme
Quantitative coagulation cascade disruptionActive Site Binding
High-affinity binding to factor Xa active site
Essential for anticoagulant efficacyOral Bioavailability
Predictable absorption and bioavailability profile
Enables consistent therapeutic anticoagulationDual Elimination
Hepatic metabolism and renal excretion pathways
Balanced clearance mechanismsRegulatory Compliance & Documentation
Comprehensive regulatory compliance ensures global pharmaceutical access with complete documentation packages supporting international standards and pharmaceutical manufacturing validations.
USP Specifications
United States Pharmacopeia pharmaceutical standards compliance
EP Standards
European Pharmacopoeia specifications for pharmaceutical analysis
ICH Guidelines
International Conference on Harmonization pharmaceutical compliance
FDA Registration
United States Food and Drug Administration compliance
Method Validation
Supported analytical method validation documentation
SDS Documentation
Multi-language Safety Data Sheets (16 sections, GHS compliant)
Technical Support & Value-Added Services
DRAVYOM's pharmaceutical development team provides comprehensive formulation support, stability testing assistance, and regulatory services to optimize pharmaceutical grade Apixaban performance in your specific therapeutic applications.
Formulation Development
- Pharmaceutical formulation optimization support
- Stability testing guidance
- Bioavailability and bioequivalence validation
- Custom pharmaceutical procedures
Analytical Services
- Certificate of Analysis verification
- Custom purity analysis
- Impurity profiling and identification
- Method validation support
Technical Support
- Pharmaceutical troubleshooting consultation
- Storage and handling guidance
- Safety training and protocols
- Manufacturing best practices
Supply Solutions
- Consistent batch scheduling
- Emergency supply arrangements
- Custom packaging options
- Global distribution network
Environmental Impact & Sustainability
Our pharmaceutical grade Apixaban production emphasizes environmental responsibility through sustainable manufacturing practices, waste minimization, and comprehensive environmental impact management for pharmaceutical operations.
Waste Minimization
Optimized production with minimal waste generation
Water Treatment
Advanced wastewater treatment and recycling systems
Clean Production
Energy-efficient synthesis with emission controls
Safe Disposal
Comprehensive guidance for pharmaceutical waste management
ISO 14001
Environmental management system certified production
Container Recycling
Pharmaceutical container return and recycling programs
Manufacturing Excellence & Quality Control
DRAVYOM's state-of-the-art pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent pharmaceutical grade Apixaban quality and performance across all production batches.
Production Process
Advanced synthesis and purification in controlled cGMP environment
Multi-stage purification for pharmaceutical grade qualityQuality Testing
Comprehensive analytical testing protocol including purity, impurities, and stability
HPLC verification and spectroscopic analysisQuality Systems
ISO 9001:2015 quality management with pharmaceutical manufacturing accreditation
Continuous improvement and process validationPackaging Control
Pharmaceutical containers with controlled atmosphere packaging
Stability protection and contamination preventionMarket Applications & Performance Data
Comprehensive pharmaceutical development data demonstrating pharmaceutical grade Apixaban effectiveness across diverse therapeutic applications with quantified performance metrics and clinical study validations.
Pharmaceutical Manufacturing
Research Institutions
Generic Manufacturing
DRAVYOM Competitive Advantages
Superior Purity
Consistently exceeds pharmaceutical specifications with ultra-low impurities and exceptional therapeutic performance
Reliable Supply
Guaranteed availability with strategic inventory management and pharmaceutical-grade production scheduling
Pharmaceutical Expertise
Dedicated pharmaceutical development team provides formulation and regulatory support
Quality Assurance
Traceable certificates with comprehensive analytical data and regulatory compliance support
Global Standards
International compliance with USP, EP, and ICH specifications for worldwide acceptance
Partnership Approach
Collaborative relationships with pharmaceutical manufacturers and custom development services